Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-managed versus physician-managed titration of insulin glargine U300 in insulin-naive adults with type 2 diabetes
2015-001167-39Phase 4Completed
- Sponsor
- Sanofi
- Start
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Primary endpoint: Change in HbA1c from baseline to Week 24. Started Apr 2015; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-001167-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001167-39.